Entrada Therapeutics, Inc. (TRDA) Payments to Acquire Property, Plant, and Equipment USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Entrada Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2021 to 2024.
  • Entrada Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $838 K, a 49.8% decline year-over-year.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $5.61 M, a 94.5% increase from 2022.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $2.89 M, a 37% decline from 2021.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $4.58 M, a 97.6% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $838 K -$830 K -49.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $1.67 M +$1.07 M +181% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $594 K -$314 K -34.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $908 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.